GYRE
Gyre Therapeutics, Inc. - Common Stock (GYRE)
$21
About Gyre Therapeutics, Inc. - Common Stock (GYRE)
Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). The firm operates through the BC and Gyre segments. The company was founded on March 7, 1997 and is headquartered in San Diego, CA.
Details
Daily high
$7.51
Daily low
$7.21
Price at open
$7.51
52 Week High
$19.00
52 Week Low
$6.11
Market cap
651.2M
Dividend yield
0.00%
Volume
53,994
Avg. volume
176,578
P/E ratio
150.52
Gyre Therapeutics, Inc. - Common Stock News
Details
Daily high
$7.51
Daily low
$7.21
Price at open
$7.51
52 Week High
$19.00
52 Week Low
$6.11
Market cap
651.2M
Dividend yield
0.00%
Volume
53,994
Avg. volume
176,578
P/E ratio
150.52